Is TRVI or TVRD more undervalued in 2026?

CirclFi compares Trevi Therapeutics, Inc. (TRVI) and Tvardi Therapeutics, Inc. (TVRD) using 13 institutional-grade valuation models. TRVI has a Quality of Company score of 4.2/10 while TVRD scores 4.1/10.

Which is a better buy — TRVI or TVRD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TRVI and TVRD valuations compare?

TRVI at $14.45 and TVRD at $3.49 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TRVI vs TVRD Valuation Comparison 2026 — Intrinsic Value Analysis

TRVI

Biotechnology

Trevi Therapeutics, Inc.

Quality

4.2

out of 10

Value Trap

LOW

Price

$14.45

Last close

Models

7/13

Active

TVRD

Biotechnology

Tvardi Therapeutics, Inc.

Quality

4.1

out of 10

Value Trap

LOW

Price

$3.49

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	TRVI Fair Value	TRVI Upside	TVRD Fair Value	TVRD Upside
Bayesian DCF	Intrinsic	$4.39	-69.7%	$2.17	-28.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.40	-97.3%	$2.73	-21.7%
Dynamic NAV	Asset-Based	$1.06	-92.6%	$3.04	-3.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TRVI vs TVRD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TRVI vs TVRD — Which Stock Is More Undervalued?

TRVI scores higher with a 4.2/10 quality rating vs TVRD's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Trevi Therapeutics, Inc. (TRVI) and Tvardi Therapeutics, Inc. (TVRD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TRVI currently trades at $14.45 with a QOC of 4.2/10, while TVRD trades at $3.49 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).